Parallax Volatility Advisers’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100,000
Closed -$1.27M 2180
2024
Q2
$1.27M Buy
100,000
+75,000
+300% +$755K ﹤0.01% 1185
2024
Q1
$120K Sell
25,000
-170,000
-87% -$788K ﹤0.01% 1592
2023
Q4
$936K Sell
195,000
-1,600
-0.8% -$9.79K ﹤0.01% 1432
2023
Q3
$1.42M Buy
+196,600
New +$1.57M ﹤0.01% 1225
2022
Q4
Sell
-66,000
Closed -$1.2M 3140
2022
Q3
$1.2M Sell
66,000
-91,500
-58% -$3.96M ﹤0.01% 1664
2022
Q2
$8.1M Sell
157,500
-172,100
-52% -$8.91M 0.01% 804
2022
Q1
$24.3M Sell
329,600
-288,000
-47% -$25.7M 0.01% 439
2021
Q4
$88.4M Buy
617,600
+63,900
+12% +$11M 0.1% 135
2021
Q3
$115M Buy
553,700
+454,500
+458% +$100M 0.11% 136
2021
Q2
$21.1M Sell
99,200
-800
-0.8% -$147K 0.03% 353
2021
Q1
$18.1M Sell
100,000
-96,800
-49% -$19.3M 0.04% 291
2020
Q4
$21.9M Buy
+196,800
New +$20.9M 0.02% 502
2019
Q2
Sell
-25,000
Closed -$275K 3353
2019
Q1
$275K Buy
+25,000
New +$789K ﹤0.01% 1761
2016
Q1
Sell
-500
Closed -$84K 3288
2015
Q4
$84K Hold
500
﹤0.01% 2179
2015
Q3
$71K Buy
+500
New +$112K ﹤0.01% 2086
2015
Q1
Sell
-13,750
Closed -$1.63M 5137
2014
Q4
$1.63M Hold
13,750
﹤0.01% 1185
2014
Q3
$1.15M Buy
+13,750
New +$1.24M ﹤0.01% 1397

Other funds holding NVAX

Parallax Volatility Advisers's NVAX Position: Q3 2024 in Review

Parallax Volatility Advisers sold out of Novavax (NVAX) in Q3 2024, closing a stake of 19,588 shares — an estimated $248K sold.

Parallax Volatility Advisers first reported a position in NVAX in Q3 2014 and held it in 18 quarters. The position peaked at $29.3M in Q4 2021. 237 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

  • Parallax Volatility Advisers reported no remaining Novavax position as of Q3 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 19,588 Novavax shares in Q3 2024, an estimated $248K.
  • Parallax Volatility Advisers first reported a position in Novavax in Q3 2014 and held it in 18 quarters.
  • Parallax Volatility Advisers's Novavax position peaked at $29.3M in Q4 2021.
  • 237 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on Parallax Volatility Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.